Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Changes in Stockholders' Equity

v3.24.1.1.u2
Condensed Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2022 $ 2 $ 117,717 $ (71,480) $ 46,239
Balance (in shares) at Dec. 31, 2022 20,861,315      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance costs $ 0 (2) 0 (2)
Stock-based compensation $ 0 804 0 804
Stock-based compensation (in shares) 68,646      
Exercise of warrants $ 0 0 0 0
Exercise of warrants (in shares) 17,869      
Net and comprehensive income (loss) $ 0 0 (5,791) (5,791)
Balance at Mar. 31, 2023 $ 2 118,519 (77,271) 41,250
Balance (in shares) at Mar. 31, 2023 20,947,830      
Balance at Dec. 31, 2023 $ 2 131,370 (81,466) 49,906
Balance (in shares) at Dec. 31, 2023 23,977,491      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 1 2,478 0 2,479
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 1,000,550      
Issuance costs $ 0 (165) 0 (165)
Stock-based compensation $ 0 985 0 985
Stock-based compensation (in shares) 120,516      
Share repurchases for the payment of employee taxes $ 0 (42) 0 (42)
Share repurchases for the payment of employee taxes (in shares) (12,965)      
Net and comprehensive income (loss) $ 0 0 (7,106) (7,106)
Balance at Mar. 31, 2024 $ 3 $ 134,626 $ (88,572) $ 46,057
Balance (in shares) at Mar. 31, 2024 25,085,592